Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUT00063 in Subjective Tinnitus (QUIET-1)
NCT02315508Phase 2Completed
- Sponsor
- Autifony Therapeutics
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
A Phase 2 trial of AUT00063 in tinnitus, sponsored by Autifony Therapeutics. Started Oct 2014; status: completed.
02
Drugs
AUT00063
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT02315508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315508.